Nicolas Villain / Moved to LinkedIn & BlueSky
@nvillain_alz
Followers
998
Following
2K
Statuses
3K
Moved to LinkedIn Neurologist Researcher #Alzheimer #Dementia #Neurodegeneration @FaculteSanteSU @Sorbonne_Univ_ @HopPitieSalpe @APHP @InstitutCerveau
Paris, France
Joined August 2022
Dear all, After two intense years on Twitter filled with passionate exchanges, I've decided to switch to LinkedIn. While the platform is changing, I’m looking forward to connecting without the anxiety-inducing posts and far-right debates. See you soon on LinkedIn!
2
0
25
RT @brnovsk: Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country…
0
11
0
RT @SegobinShail: TANGO's first dance is here ! We dissect the issues regarding human thalamic nuclei imaging and…
0
10
0
RT @NIH: The MIND diet, a diet that has key elements of the Mediterranean and DASH diets, was linked to reduced risk of cognitive decline i…
0
30
0
RT @ArenazaEider: 🚨Paper alert In a cohort at increased #Alzheimer risk: Glial markers independently contributed to the A/T/N & to sex/ge…
0
9
0
@PAULJLAMONT @pash22 @dr_shibley @EWidera @MemoryDoc @LogarithmicDis @LonSchneiderMD @Jeff_Browndyke @AlbertoEspay @seb_walsh @LTCShop @ProfRobHoward @MadhavThambiset @KasperKepp @RenegadeSynapse @DanielErsk1ne @PhilAlz @_michael_scholl @VincentPlanche @StefanoSensi14 @Gill_Livingston @DrTFromKC @jfballenger @jasonkarlawish @JamesRuFletcher @AdamMBrickman @ManlyEpic @SFAckley @howard_gleckman @kathy_y_liu @r_merrick @nlundebjerg @NathanielChinMD @EmmyBetz @DrJoRyan @MaggieAime @OskarHansson9 @DavidJonesBrain @PTenigma @Ayisha_Sharma97 @adamhdyer @DrewQJoseph @jocelynkaiser @jmschott @ayton_scott @Kariem_Ezzat @jesse_brodkin @CassavaSciences @MeaganParrish Depends on the border and the barrier 😬🙃
1
0
2
RT @_JakeVogel_: @lemwisse and I are involved in a super cool project to advance our ability to measure spatially-resolved omics data from…
0
15
0
RT @gesalbla: Sooooooo important! Sometimes a coffee with a science buddy may help you overcome that problem that you have been thinking ab…
0
3
0
RT @M_SuarezCalvet: 📢 POSTDOC position at @biofinder_study @BarcelonaBeta still open! 👩🏽💻🧑🏿💻👩🏻💻🧠📊 📩 Contact us for more info! https:…
0
22
0
RT @narologist: Multiple Sclerosis is entering its 2024 ERA – that means new treatments on the horizon and a new changes to the McDonald DI…
0
181
0
RT @SantPauMemory: 🌟Excited to announce a new series in @LancetLongevity & @eBioMedicine that addresses the challenges of integrating #bio…
0
9
0
RT @_michael_scholl: Out now: our review on the challenges in the practical implementation of blood-based biomarkers for #Alzheimer’s Big…
0
15
0
RT @matbrendel: 🚨 Just out in Theranostics: ☢️ we developed a new microglia specific Cu64-labeled TREM2-PET radiotracer ☢️ importantly this…
0
10
0
RT @ProfRobHoward: Problems with biomarker-based diagnoses of Alzheimer's disease. Our new piece in @GreenJournal, led by the brilliant @Ha…
0
20
0
RT @eumind_congress: ➡️The 1st edition of #EUMIND2024 has come to an end 🧠 We’re truly grateful to all the researchers, postdocs, PhD stude…
0
4
0
RT @_michael_scholl: Excited to share the REAL AD design paper, now out in @alzdemjournals The study has been live for 5 months, and we a…
0
9
0
RT @smead2: Finally got to read @AlbertoEspay nice paper on Abeta42 in AD trials. It's good to promote alternative mechanisms and glad this…
0
4
0
RT @eumind_congress: ➡️Thanks to Dr Renaud La Joie for his amazing presentation about “Neuroimaging in the era of anti-amyloid therapies” d…
0
4
0